Status:
COMPLETED
Study Evaluating Renal Cell Carcinoma Risk Factors
Lead Sponsor:
Pfizer
Conditions:
Carcinoma, Renal Cell
Eligibility:
All Genders
18+ years
Brief Summary
This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patien...
Detailed Description
invitation to volunteer
Eligibility Criteria
Inclusion
- Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery or radiotherapy)
- =18 years, any gender.
- Patients with advanced Renal Cell Carcinoma and treatment naïve.
Exclusion
- Patients who have already initiated any kind of specific therapy for the treatment of RCC.2.
- Patients with other neoplasias different from RCC (current or past).
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT00927043
Start Date
May 1 2009
End Date
September 1 2011
Last Update
November 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Pamplona, Navarre, Spain, 31008